Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial)

Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial)

Abstract Background Esophagectomy is still advised as an additional treatment for pathological T1b (pT1b) esophageal squamous cell carcinoma (ESCC) following attempted endoscopic resection (ER). ER followed with definitive chemoradiotherapy (dCRT) has shown increased quality of life as well as compa...

Full description

Bibliographic Details
Main Authors: Yang Yang, Yuchen Su, Xiaobin Zhang, Jun Liu, Hong Zhang, Bin Li, Rong Hua, Lijie Tan, Hezhong Chen, Zhigang Li
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Trials
Subjects:
Esophageal cancer
Submucosal lesion
Endoscopic submucosal dissection
Definitive chemoradiotherapy
Esophagectomy
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-020-04461-5

Internet

http://link.springer.com/article/10.1186/s13063-020-04461-5

Similar Items